Rethinking Uncomplicated UTIs: A Comprehensive Review of Diagnosis, Management, and Novel and Emerging Treatment Options
1.00 AMA PRA Credits
Meeting Information
Overview
Learning Objectives
CME/ Information
Faculty and Disclosures
Instructions
Program Overview
The high prevalence and significant personal and healthcare impact and the advancements in UTI management highlight the importance of accurate diagnosis, streamlined treatment protocols, and optimizing patient care.
HCPs must remain familiar with the classification of UTIs, the common signs and symptoms of uncomplicated UTIs, readily available diagnostic tools, and appropriate antibiotic selection based on local resistance patterns. Furthermore, staying updated on evolving antibiotic resistance trends and the potential need for alternative therapies is crucial.
Effective management also requires clear communication and collaboration within healthcare teams to ensure optimal patient outcomes. This includes providing standardized education and support for patients to understand their condition, treatment options, and preventative measures.
By focusing on these collective efforts, we can ensure the best possible care for patients with uncomplicated UTIs and minimize the risk of complications.
HCPs must remain familiar with the classification of UTIs, the common signs and symptoms of uncomplicated UTIs, readily available diagnostic tools, and appropriate antibiotic selection based on local resistance patterns. Furthermore, staying updated on evolving antibiotic resistance trends and the potential need for alternative therapies is crucial.
Effective management also requires clear communication and collaboration within healthcare teams to ensure optimal patient outcomes. This includes providing standardized education and support for patients to understand their condition, treatment options, and preventative measures.
By focusing on these collective efforts, we can ensure the best possible care for patients with uncomplicated UTIs and minimize the risk of complications.
Target Audience
This educational initiative is designed for primary care physicians, physician assistants, nurse practitioners, nurses and other healthcare professionals in primary care.
Supporter Acknowledgement
This educational activity is supported by an independent educational grant from GSK.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- APPLY evidence-based guidelines to accurately interpret signs, symptoms, and laboratory test results for diagnosing uUTIs.
- UTILIZE evidence-based guidelines in selecting antimicrobial therapy for uncomplicated UTIs, thereby minimizing unnecessary antibiotic use.
- REVIEW the key factors contributing to treatment failure in patients with uncomplicated urinary tract infections.
- EVALUATE the impact of uUTI and treatment failure on patient well-being.
- INTEGRATE patient education and shared decision-making into their management of uUTIs,.
Accredited Provider
This activity is jointly provided by Global Education Group and Iridium Continuing Education.


AMA PRA Category 1 Credit™
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Designation Statement
Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty, Staff, and Planners’ Disclosures
Global
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
Iridium
The planners and managers at Iridium have no relevant financial relationships to disclose.
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
Iridium
The planners and managers at Iridium have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Matt T. Rosenberg, MD
Director, Mid Michigan Health Centers
Jackson, MI
Jackson, MI
disclosures
Instructions to Receive Credit
In order to receive credit for this activity, the participant must:
A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.
- Read the learning objectives and faculty disclosures
- Complete the pretest
- Attend the live meeting or satellite symposia
- Complete the posttest with a score of 70% or higher
- Complete the evaluation
A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com
System Requirements
2025 Winter Family Physicians Weekend
December 4-7, 2025
Location
Omni Grove Park Inn
290 Macon Ave,
Asheville, NC 28804
290 Macon Ave,
Asheville, NC 28804
Supporter Acknowledgement
This educational activity is supported by an independent educational grant from GSK.

Copyright © 2025



Stay Informed
To receive updates as soon as the new dates are confirmed, please share your email.
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
Thank you!